Literature DB >> 15710933

Intravaginal and intrarectal microbicides to prevent HIV infection.

Jan Balzarini1, Lut Van Damme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15710933      PMCID： PMC548403          DOI： 10.1503/cmaj.1041462

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

Authors:  Lut Van Damme; Gita Ramjee; Michel Alary; Bea Vuylsteke; Verapol Chandeying; Helen Rees; Pachara Sirivongrangson; Léonard Mukenge-Tshibaka; Virginie Ettiègne-Traoré; Charn Uaheowitchai; Salim S Abdool Karim; Benoît Mâsse; Jos Perriëns; Marie Laga
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

2.  A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women.

Authors:  L Van Damme; A Wright; K Depraetere; I Rosenstein; V Vandersmissen; L Poulter; M McKinlay; E Van Dyck; J Weber; A Profy; M Laga; V Kitchen
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

3.  Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study.

Authors:  C Mauck; D H Weiner; S Ballagh; M Creinin; D F Archer; J Schwartz; H Pymar; J J Lai; M Callahan
Journal:  Contraception       Date:  2001-12       Impact factor: 3.375

4.  Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection.

Authors:  Jan Balzarini; Sigrid Hatse; Kurt Vermeire; Katrien Princen; Stefano Aquaro; Carlo-Federico Perno; Erik De Clercq; Herman Egberink; Guy Vanden Mooter; Willy Peumans; Els Van Damme; Dominique Schols
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191
  4 in total
  8 in total

1.  She's dying for help: global HIV.

Authors:  Sally Murray
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

Review 2.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

3.  Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.

Authors:  Philippe Selhorst; Ana C Vazquez; Katty Terrazas-Aranda; Johan Michiels; Katleen Vereecken; Leo Heyndrickx; Jan Weber; Miguel E Quiñones-Mateu; Kevin K Ariën; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

Review 4.  Microbicides in the prevention of HIV infection: current status and future directions.

Authors:  Jeremy Nuttall
Journal:  Drugs       Date:  2010-07-09       Impact factor: 9.546

5.  Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.

Authors:  Radiana T Trifonova; Jenna-Malia Pasicznyk; Raina N Fichorova
Journal:  Antimicrob Agents Chemother       Date:  2006-10-09       Impact factor: 5.191

6.  Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.

Authors:  Katty Terrazas-Aranda; Yven Van Herrewege; Daria Hazuda; Paul Lewi; Roberta Costi; Roberto Di Santo; Andrea Cara; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

7.  The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics.

Authors:  David P Wilson; Paul M Coplan; Mark A Wainberg; Sally M Blower
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

8.  Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.

Authors:  Santhosh Chakkaramakkil Verghese; Natalya A Goloviznina; Peter Kurre
Journal:  Stem Cell Res Ther       Date:  2016-11-19       Impact factor: 6.832
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.